Ausgabe Sonderheft 1/2005
Inhalt (5 Artikel)
Efalizumab, a reversible T-cell modulator for psoriasis
Neil H. Shear, Richard G. Langley, Vincent Ho
A favourable benefit/risk ratio with efalizumab: A review of the clinical evidence
Yves Poulin, Kim A. Papp, Wayne Carey, Wayne Gulliver, Aditya K. Gupta
Recommendations for incorporating biologicals into management of moderate to severe plaque psoriasis: individualized patient approaches
Richard G. Langley, Vincent Ho, Charles Lynde, Kim A. Papp, Yves Poulin, Neil Shear, Jack Toole, Catherine Zip
Strategies for optimizing treatment with efalizumab in moderate to severe psoriasis
Kim A. Papp, Vincent Ho, Richard Langley, Charles Lynde, Yves Poulin, Neil Shear, John Toole, Catherine Zip